高级检索
当前位置: 首页 > 详情页

The Potential of Nano Pharmaceuticals to Change the Paradigm of Brain Tumor Therapy: A State-of-the-Art Review

文献详情

资源类型:
Pubmed体系:
机构: [1]Cardiff University School of Medicine, Cardiff University, Cardiff, Wales, UK [2]PearResearch, Dehradun, India [3]Lebanese University, Faculty of Medical Sciences, Beirut, Lebanon [4]Northeast Ohio Medical University, Ohio, USA [5]Uzhhorod National University, Uzhhorod, Ukraine [6]University of Bologna, Bologna, Italy [7]UCMS and GTB Hospital, Delhi [8]Department of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, 602105, India [9]Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Tampa Bay Regional Campus, Clearwater, Florida, USA [10]Joint Laboratory of Artificial Intelligence in Healthcare, West China School of Nursing and Institutes for Systems Genetics, Frontiers Science Center for Disease- related Molecular Network, West China Hospital, Sichuan University, China [11]King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia [12]Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh [13]Enzymoics, 7 Peterlee place, Hebersham, NSW 2770/Novel Global Community Educational Foundation, Australia [14]Government Doon Medical College, Dehradun, Uttarakhand, India
出处:
ISSN:

关键词: Brain tumor blood-brain barrier nano-pharmaceuticals nanomedicine liposome neuro-oncology

摘要:
Central nervous system tumors are abnormal proliferations of neuronal cells within the brain and spinal cord. They can be primary or secondary and place a heavy financial, psychological, and physical burden on individuals. The highly selective blood-brain barrier, which only permits specific molecules to flow into the brain parenchyma, inhibits the efficacy of pharmacological medicines. Treatment options include surgery, chemoradiotherapy, and targeted therapy. Despite advances in therapy over the past few decades, the overall morbidity and mortality rates are still high, emphasizing the need for improved therapeutic choices to improve survival and quality of life further. Nano pharmaceuticals have demonstrated encouraging outcomes in in vivo trials using microscopic particles to enhance bioavailability and selectivity. The most successful clinical results to date have been achieved by liposomes, extracellular vesicles, and biomimetic nanoparticles; nevertheless, clinical trials are required to confirm their safety, efficacy, affordability, longterm impact, and success in patients from various demographics. Nano pharmaceuticals have the potential to change the paradigm of therapy for brain tumors, allowing better outcomes as primary and adjunctive therapy.Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
第一作者:
第一作者机构: [1]Cardiff University School of Medicine, Cardiff University, Cardiff, Wales, UK [2]PearResearch, Dehradun, India
通讯作者:
通讯机构: [2]PearResearch, Dehradun, India [10]Joint Laboratory of Artificial Intelligence in Healthcare, West China School of Nursing and Institutes for Systems Genetics, Frontiers Science Center for Disease- related Molecular Network, West China Hospital, Sichuan University, China [11]King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia [12]Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh [13]Enzymoics, 7 Peterlee place, Hebersham, NSW 2770/Novel Global Community Educational Foundation, Australia [14]Government Doon Medical College, Dehradun, Uttarakhand, India [*1]Joint Laboratory of Artificial Intelligence in Healthcare, West China School of Nursing and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, China
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]Customizing delivery nano-vehicles for precise brain tumor therapy [2]Molecular Identity Changes of Tumor-Associated Macrophages and Microglia After Magnetic Resonance Imaging-Guided Focused Ultrasound-Induced Blood-Brain Barrier Opening in a Mouse Glioblastoma Model [3]Chronic cerebral hypoperfusion and blood-brain barrier disruption in uninjured brain areas of rhesus monkeys subjected to transient ischemic stroke. [4]Corrigendum to 'Molecular Identity Changes of Tumor-Associated Macrophages and Microglia After Magnetic Resonance Imaging-Guided Focused Ultrasound-Induced Blood-Brain Barrier Opening in a Mouse Glioblastoma Model' [Ultrasound in Med & Biol. 49 (2023) 1082-1090 [5]Focused ultrasound-mediated blood-brain barrier opening combined with magnetic targeting cytomembrane based biomimetic microbubbles for glioblastoma therapy [6]Ligand-Installed Nanocarriers toward Precision Therapy. [7]Establishing a clinically relevant orthotopic xenograft model of patient-derived glioblastoma in zebrafish. [8]Intestinal dysbiosis exacerbates susceptibility to the anti-NMDA receptor encephalitis-like phenotype by changing blood brain barrier permeability and immune homeostasis [9]Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii [10]Fecal Microbiota Transplantation-Mediated Ghrelin Restoration Improves Neurological Functions After Traumatic Brain Injury: Evidence from 16S rRNA Sequencing and In Vivo Studies

资源点击量:53699 今日访问量:0 总访问量:4607 更新日期:2025-02-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号